Effects of Glycemic Variability on Regulatory T Cells in Patients with Type 2 Diabetes and Kidney Disease

被引:1
|
作者
Gu, Qing-Wei [1 ]
Sun, Qi [1 ]
Wang, Jie [1 ]
Gu, Wen-Sha [1 ]
Wang, Wei [1 ]
Mao, Xiao-Ming [1 ]
机构
[1] Nanjing Med Univ, Nanjing Hosp 1, Dept Endocrinol, 68 ChangLe St, Nanjing 210006, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
type 2 diabetes mellitus; diabetic kidney disease; glycemic variability; regulatory T cells; inflammatory cytokines; INFLAMMATION; NEPHROPATHY; MECHANISMS; PATHOGENESIS; RISK;
D O I
10.2147/DMSO.S413407
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To investigate the pathogenesis of diabetic kidney disease (DKD) in type 2 diabetes mellitus (T2DM), we evaluated the effects of short-term glycemic variability (GV) on the profile of T cell subpopulations.Methods: A total of 47 T2DM patients with normoalbuminuria, 47 microalbuminuria, and 49 macroalbuminuria were enrolled. The continuous glucose monitoring (CGM) determined the GV of enrolled patients. Flow cytometry was used to determine the proportion of T cell subpopulations.Results: The frequency of T helper (Th) 17 and Th1 cells significantly increased while regulatory T cells (Tregs) significantly decreased in the macroalbuminuria group compared to normoalbuminuria and microalbuminuria groups (P < 0.01). The suppressive function of Tregs was significantly lower in the macroalbuminuria group than the normoalbuminuria group (P < 0.05). Compared with the normoalbuminuria group, the mean amplitude of glucose excursions (MAGE) of the macroalbuminuria group was significantly higher (P<0.05). Furthermore, there were negative associations between the proportion of Tregs and MAGE.Conclusions: Increased GV could decrease the proportion of Tregs and may impair their function. This may lead to increases in Th1 and Th17 cells, and some inflammatory cytokines, which might contribute to the development and progression of DKD in T2DM.
引用
收藏
页码:2365 / 2375
页数:11
相关论文
共 50 条
  • [41] Glycemic Variability in Patients with Type 2 Diabetes Mellitus: Clinical Implications and Pharmacological Considerations
    Howsawi, Alanood
    Alem, Manal
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 118 - 119
  • [42] Relationship between glycemic variability and cognitive function in lacune patients with type 2 diabetes
    Qi-Zhe Meng
    Yang Wang
    Bing Li
    Zhi Xi
    Ming Wang
    Jia-Qi Xiu
    Xiao-Peng Yang
    World Journal of Clinical Cases, 2023, (05) : 1019 - 1030
  • [43] Clinical implications and pharmacological considerations of glycemic variability in patients with type 2 diabetes mellitus
    Howsawi, Alanood A.
    Alem, Manal M.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [44] REDUCTION OF GLYCEMIC VARIABILITY (GV) BY HAEMODIALYSIS IN TYPE 2 DIABETES
    Proietti, A.
    Daghero, A.
    Nogueira, J. P.
    Iglesias, M. L.
    De Marziani, G.
    Elbert, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A99 - A100
  • [45] Glycemic variability: Too often overlooked in type 2 diabetes?
    Johnson, Eric L.
    JOURNAL OF FAMILY PRACTICE, 2010, 59 (08): : E1 - E8
  • [46] Glycemic Variability among Older Adults with Type 2 Diabetes
    Tong, Chin Voon
    Noor, Nurain Mohd
    Mohamad, Masni
    Nesaratnam, Shalena
    Hussein, Zanariah
    JOURNAL OF DIABETES & METABOLISM, 2016, 7 (02)
  • [47] RETRACTED: Heart Rate Variability and Chronic Kidney Disease in Patients with Type 2 Diabetes (Retracted Article)
    Shi, Wei
    Zhang, Jing
    Chen, Dan
    Chen, Xiaolei
    Duan, Wei
    Zhang, Hongmei
    APPLIED BIONICS AND BIOMECHANICS, 2022, 2022
  • [48] Effects of Qidan Tangshen Granule on diabetic kidney disease in patients with type 2 diabetes
    Yang, Hua
    Xia, Shisi
    Cong, Yilei
    Yang, Xinyu
    Min, Jie
    Wu, Tengfei
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 209
  • [49] Evaluation of glycemic variability in chronic liver disease patients with type 2 diabetes mellitus using continuous glucose monitoring
    Honda, Fumi
    Hiramatsu, Akira
    Hyogo, Hideyuki
    Aikata, Hiroshi
    Daijo, Kana
    Teraoka, Yuji
    Inagaki, Yuki
    Morio, Kei
    Kobayashi, Tomoki
    Nakahara, Takashi
    Nagaoki, Yuko
    Kawaoka, Tomokazu
    Yoneda, Masayasu
    Tsuge, Masataka
    Imamura, Michio
    Kawakami, Yoshiiku
    Ochi, Hidenori
    Chayama, Kazuaki
    PLOS ONE, 2018, 13 (04):
  • [50] Comparison of Insulin Detemir and Insulin Glargine on Glycemic Variability in Patients with Type 1 and Type 2 Diabetes
    Tone, A.
    Iseda, I.
    Higuchi, C.
    Tsukamoto, K.
    Katayama, A.
    Matsushita, Y.
    Hida, K.
    Wada, J.
    Shikata, K.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2010, 118 (05) : 320 - 324